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Abstract
Background: Nitric oxide generated by neuronal (NOS1), inducible (NOS2) or endothelial (NOS3) nitric oxide synthases
contributes to pain processing, but the exact role of NOS1 and NOS2 in the maintenance of chronic peripheral neuropathic
pain as well as the possible compensatory changes in their expression in the spinal cord of wild type (WT) and NOS
knockout (KO) mice at 21 days after total sciatic nerve ligation remains unknown.
Methodology/Principal Findings: The mechanical and thermal allodynia as well as thermal hyperalgesia induced by sciatic
nerve injury was evaluated in WT, NOS1-KO and NOS2-KO mice from 1 to 21 days after surgery. The mRNA and protein levels
of NOS1, NOS2 and NOS3 in the spinal cord of WT and KO mice, at 21 days after surgery, were also assessed. Sciatic nerve
injury led to a neuropathic syndrome in WT mice, in contrast to the abolished mechanical allodynia and thermal
hyperalgesia as well as the decreased or suppressed thermal allodynia observed in NOS1-KO and NOS2-KO animals,
respectively. Sciatic nerve injury also increases the spinal cord expression of NOS1 and NOS2 isoforms, but not of NOS3, in
WT and NOS1-KO mice respectively. Moreover, the presence of NOS2 is required to increase the spinal cord expression of
NOS1 whereas an increased NOS1 expression might avoid the up-regulation of NOS2 in the spinal cord of nerve injured WT
mice.
Conclusions/Significance: These data suggest that the increased spinal cord expression of NOS1, regulated by NOS2, might
be responsible for the maintenance of chronic peripheral neuropathic pain in mice and propose these enzymes as
interesting therapeutic targets for their treatment.
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Introduction
Neuropathic pain is a clinical manifestation characterized by the
presence of exaggerated response to painful stimuli (hyperalgesia),
pain response to normally innocuous stimuli (allodynia), and
spontaneous pain. It is well accepted that nitric oxide synthesized
by three nitric oxide synthases (neuronal, NOS1; inducible, NOS2
and endothelial, NOS3) regulates several cellular processes, such
as pathological pain [1–2]. Therefore, several works using
pharmacological and genetic approaches have demonstrated that
selective NOS1 and NOS2 inhibitors might reverse the mechan-
ical hypersensitivity to pain induced by spinal and peripheral
neuropathy [3–5]. However and besides that these studies suggest
a potential role of nitric oxide in the modulation of nerve injury-
induced mechanical hypersensitivity, the exact contribution of
NOS1 and NOS2 in the modulation of the thermal hyperalgesia
and thermal allodynia induced by sciatic nerve injury remains
unknown. Thus, the first aim of our study is to compare the pain-
related behavior induced by the chronic constriction of the sciatic
nerve in NOS1-KO, NOS2-KO and WT mice from days 1 to 21
after nerve injury.
Several works have demonstrated that nerve injury after sciatic
nerve ligation evoked an increased NOS1 and NOS2, but not of
NOS3, protein expression in the ipsilateral site of the dorsal root
ganglia and the sciatic nerve [4,6–11]. In contrast, the possible
changes induced by peripheral neuropathic pain in the spinal cord
expression of these genes remain controversial. That is, from no
changes to an increased NOS protein expression in the spinal cord
of sciatic nerve-injured animals at days 7
th to 26
th after surgery
have been reported [4,7–8,11]. Therefore, our subsequent aim is
to evaluate the mRNA and protein expression of NOS1 and
NOS2 isoenzymes in the spinal cord of WT mice at 21 days after
sciatic nerve ligation and correlate it with their corresponding
behavior responses.
It is well known that the expression of other NOS isoforms is up-
regulated in a compensatory manner in the spinal cord of NOS1
and NOS2 knockout mice under basal and inflammatory pain
conditions [12–14]. However, the possible changes in the
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in the spinal cord of NOS1 and NOS2 knockout mice after total
sciatic nerve ligation remains unknown. Thus, the mRNA and
protein levels of these three isoenzymes (NOS1, NOS2 and NOS3)
in the spinal cord of NOS2-KO and NOS1-KO mice at day 21
after sciatic nerve injury were also evaluated.
Results
Effect of NOS1 and NOS2 deletion on the development
of neuropathic pain in mice
Mechanical allodynia. Sciatic nerve ligature led to a
significant decrease of the threshold for evoking paw withdrawal
to a mechanical stimulus only in WT mice and this response was
abolished in mice lacking NOS1 or NOS2 (Fig. 1A). Baseline
values were similar in all genotypes. Sham operation did not
produce any modification of the nociceptive responses in WT,
NOS1-KO or in NOS2-KO mice for the whole duration of the
experiment.
For NOS1-KO mice, the two-way ANOVA revealed a
significant effect of the genotype (p,0.002) at days 4, 10, 14
and 21 after surgery, a significant effect of surgery (p,0.008) on
days 1, 4, 7, 14 and 21 and a significant interaction between
genotype and surgery from day 1 to day 21 (p,0.030) after surgery
in the ipsilateral paw of NOS1-KO mice as compared to WT
group.
In WT mice, nerve injury led to a significant decrease of the
threshold for evoking hind paw withdrawal to a mechanical
stimulus on the injured side. This mechanical allodynia appeared
on the first measurement after sciatic nerve ligation (day 1) and
persisted for the whole duration of the experiment. Indeed, a
significant effect of sciatic nerve ligation was revealed on day 1
(p,0.001), day 4 (p,0.001), day 7 (p,0.039), day 10 (p,0.017),
day 14 (p,0.007) and day 21 (p,0.001) after surgery (one-way
ANOVA vs. WT sham-operated animals). In contrast, a significant
decrease of mechanical allodynia was observed in NOS1-KO mice
on day 1 (p,0.008), day 4 (p,0.001), day 7 (p,0.001), day 10
(p,0.001), day 14 (p,0.001) and day 21 (p,0.001) when
compared to the WT group (one-way ANOVA).
The possible development of mechanical allodynia in NOS2-
KO mice after sciatic nerve injury has been also evaluated. The
two-way ANOVA revealed a significant effect of the genotype
(p,0.001) at days 4, 7, 10, 14 and 21 after surgery, a significant
effect of the surgery (p,0.023) on days 1, 10 and 21 and a
significant interaction between genotype and surgery from day 1 to
day 21 (p,0.008) after surgery in the ipsilateral paw of NOS2-KO
mice as compared to WT group. Indeed, a significant decrease of
mechanical allodynia was also observed in NOS2-KO mice on day
1( p ,0.008), day 4 (p,0.001), day 7 (p,0.001), day 10 (p,0.001),
day 14 (p,0.001) and day 21 (p,0.001) when compared to WT
group (one-way ANOVA).
Withdrawal latencies of the contralateral paw were not modified
in any experimental group (data not shown).
Thermal hyperalgesia. Sciatic nerve ligature decreased paw
withdrawal latency to thermal stimulus only in WT mice and this
response was abolished in mice lacking NOS1 or NOS2 genes
(Fig. 1B). Baseline values were similar in all genotypes. Sham
operation did not produce any modification of nociceptive
responses in WT, NOS1-KO or in NOS2-KO mice for the
whole duration of the experiment.
Regarding NOS1-KO mice, the two-way ANOVA revealed a
significant effect of the genotype (p,0.001), surgery (p,0.001) and
their interaction (p,0.005) from day 1 to day 21 after surgery in
the ipsilateral paw of NOS1-KO mice as compared to the WT
Figure 1. Effect of NOS1 and NOS2 deletion on sciatic nerve
injury induced mechanical allodynia, thermal hyperalgesia and
thermal allodynia in mice. Development of mechanical allodynia
(A), thermal hyperalgesia (B) and thermal allodynia (C) in the ipsilateral
paw of WT, NOS1-KO and NOS2-KO mice at 0, 1, 4, 7, 10, 14 and 21 days
after sciatic nerve ligation. For each test and time tested, * indicates
significant differences when compared sciatic nerve-injured WT mice vs.
sham-operated WT mice (* p,0.05, ** p,0.01, *** p,0.001, one-way
ANOVA followed by Scheffe test), + when compared sciatic nerve-
injured NOS1-KO mice vs. sciatic nerve-injured WT mice (+ p,0.05,
++ p,0.01, +++ p,0.001, one-way ANOVA followed by Scheffe test)
and # when compared sciatic nerve-injured NOS2-KO mice vs. sciatic
nerve-injured WT mice (# p,0.05, ## p,0.01, ### p,0.001, one-
way ANOVA followed by Scheffe test). In the cold plate test (C),
N indicates significant differences when compared sciatic nerve-injured
NOS1-KO mice vs. sham-operated NOS1-KO mice (N p,0.05, NN p,0.01,
one-way ANOVA followed by Scheffe test). Results are shown as mean
values 6 SEM; n=10–12 animals per experimental group.
doi:10.1371/journal.pone.0014321.g001
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withdrawal latencies was observed in the ipsilateral paw of WT
mice exposed to sciatic nerve injury from day 1 to day 21
(p,0.001) after surgery (one-way ANOVA vs. WT sham-operated
animals). In contrast, a significant decrease of thermal hyperalgesia
was observed in sciatic nerve-injured NOS1-KO mice from day 1
to day 21 (p,0.001) when compared to the WT group (one-way
ANOVA).
The possible development of thermal hyperalgesia in NOS2-
KO mice after sciatic nerve injury has been also evaluated. The
two-way ANOVA also revealed a significant effect of the genotype
(p,0.001), surgery (p,0.001) and their interaction (p,0.007)
from day 1 to day 21 after surgery in the ipsilateral paw of NOS2-
KO mice as compared to WT group. Indeed, a significant
decrease of thermal hyperalgesia was observed in sciatic nerve-
injured NOS2-KO mice from day 1 to day 21 (p,0.001) when
compared to the WT group (one-way ANOVA).
Withdrawal latencies of the contralateral paw were not modified
in any of the experimental groups (data not shown).
Thermal allodynia. Sciatic nerve ligature enhanced the
score values during the cold thermal stimulation in WT mice and
this response was significantly attenuated or abolished in NOS1-
KO and NOS2-KO mice (Fig. 1C), respectively. Baseline score
values were similar in all genotypes. Sham operation did not
produce any modification of thermal nociceptive responses neither
in WT nor in KO mice for the whole duration of the experiment.
For NOS1-KO mice, the two-way ANOVA only revealed a
significant effect of the genotype (p,0.029) at days 14 and 21 after
surgery, a significant effect of the surgery (p,0.006) on days 4, 7,
10, 14 and 21 and a significant interaction between theme at days
1 and 21 (p,0.036) after surgery in the ipsilateral paw of NOS1-
KO mice as compared to the WT group. Thus, WT mice exposed
to sciatic nerve injury significantly increased the score values after
surgery, revealing the development of thermal allodynia on day 1
(p,0.046), day 4 (p,0.028), day 7 (p,0.001), day 10 (p,0.004),
day 14 (p,0.001) and day 21 (p,0.001) after surgery (one-way
ANOVA vs. WT sham-operated animals). In NOS1-KO mice
exposed to sciatic nerve injury only showed significant thermal
allodynia on day 7 (p,0.008), day 10 (p,0.017), day 14 (p,0.050)
and day 21 (p,0.011) after surgery (one-way ANOVA vs. sham
operated animals), although a significant decrease of this thermal
allodynia was observed when compared sciatic nerve-injured
NOS1-KO vs. WT mice on days 14 (p,0.017) and 21 (p,0.001)
after surgery (one-way ANOVA).
The possible development of thermal allodynia in NOS2-KO
mice after sciatic nerve injury has been also evaluated. The two-
way ANOVA revealed a significant effect of the genotype
(p,0.011) from days 1 to 21 after surgery, a significant effect of
surgery (p,0.001) on days 7, 10, 14 and 21 and a significant
interaction between genotype and surgery from day 7 to day 21
(p,0.001) after surgery in the ipsilateral paw of NOS2-KO mice
as compared to the WT group. Thus, thermal allodynia was not
developed in NOS2-KO mice. Indeed, a significant decrease of
thermal allodynia was observed when compared sciatic nerve-
injured NOS2-KO mice on day 1 (p,0.049), day 4 (p,0.033),
day 7 (p,0.001), day 10 (p,0.001), day 14 (p,0.001) and day 21
(p,0.001) with WT mice (one-way ANOVA).
Expression of NOS1 in the spinal cord of WT and NOS2-
KO mice
The relative mRNA levels of NOS1 gene in the spinal cord
from sham-operated and sciatic nerve-injured WT and NOS2-KO
mice are shown in Fig. 2A. Our results showed that although the
two way ANOVA did not show a significant effect of the genotype
or surgery, a significant interaction between theme was demon-
strated (p,0.005). Thus, sciatic nerve ligation significantly
increased the NOS1 gene expression in WT but not in NOS2-
KO mice, when comparing sham-operated vs. sciatic nerve-
injured animals (one way ANOVA, p,0.016). Our results did not
show any significant differences between genotypes as comparing
the expression of NOS1 mRNA among theme in sham-operated
mice.
The protein expression of NOS1 in the spinal cord from sham-
operated and sciatic nerve-injured WT and NOS2-KO mice are
Figure 2. Spinal cord expression of NOS1 in WT and NOS2-KO
mice. The relative NOS1 mRNA (A) and protein (B) expression in the
ipsilateral site of the lumbar section of the spinal cord from sham-
operated (SH) and sciatic nerve-injured (SNI) WT and NOS2-KO mice at
21 days after sciatic nerve ligation are represented. In both figures,
* indicates significant differences when compared sciatic nerve-injured
WT mice vs. sham-operated WT animals (* p,0.05, one-way ANOVA
followed by Student-Newman-Keuls test). A representative example of
Western blots for NOS1 protein (155 kDa) in which b-actin (43 kDa) was
used as a loading control is shown in C. Data are expressed as mean
values 6 SEM; n=4–5 samples per group.
doi:10.1371/journal.pone.0014321.g002
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effect of the genotype (p,0.001) and a significant interaction
between genotype and surgery (p,0.003). Thus and according to
that occurs with the mRNA levels, while sciatic nerve ligation
significantly increases the NOS1 protein levels in WT mice it did
not change their expression in NOS2-KO animals, when
comparing sham-operated vs. sciatic nerve-injured animals (one
way ANOVA, p,0.001). Our results did not show any significant
differences between genotypes when comparing the expression of
NOS1 protein among theme in sham-operated mice.
The mRNA and protein levels of NOS1 gene in the spinal cord
from sham-operated and sciatic nerve-injured NOS1-KO were
undetectable (data not shown).
Expression of NOS2 in the spinal cord of WT and NOS1-
KO mice
The relative mRNA levels of NOS2 gene in the spinal cord
from sham-operated and sciatic nerve-injured WT and NOS1-KO
mice are shown in Fig. 3A. For NOS2 although the two way
ANOVA did not show any effect of the genotype or surgery, a
significant interaction between theme was demonstrated
(p,0.011). Indeed, sciatic nerve ligation did not alter the NOS2
expression in the spinal cord of WT mice, but significantly
increased their expression in NOS1-KO mice, when comparing
sham-operated vs. sciatic nerve-injured animals (one way AN-
OVA, p,0.021). Non significant differences were found between
genotypes as compared the expression of NOS2 mRNA among
theme in sham-operated mice.
The protein expression of NOS2 in the spinal cord from sham-
operated and sciatic nerve-injured WT and NOS1-KO mice are
shown in Fig. 3B. The two way ANOVA did not show any effect
of the genotype or surgery but a significant interaction between
theme was demonstrated (p,0.019). Indeed, sciatic nerve injury
did not alter the NOS2 protein levels in the spinal cord of WT
mice but significantly increased their expression in NOS1-KO
mice when comparing sham-operated vs. sciatic nerve-injured
animals (one way ANOVA, p,0.028). Non significant differences
were found between genotypes when compared the expression of
NOS2 protein among theme in sham-operated mice.
The mRNA and protein levels of NOS2 gene in the spinal cord
from sham-operated and sciatic nerve-injured NOS2-KO were
undetectable (data not shown).
Expression of NOS3 in the spinal cord of WT, NOS2-KO
and NOS1-KO mice
The relative mRNA levels of NOS3 gene in the spinal cord
from sham-operated and sciatic nerve-injured WT, NOS2-KO
and NOS1-KO mice are shown in Fig. 4A. The two way ANOVA
showed a significant effect of the genotype (p,0.001) and a
significant interaction between genotype and surgery (p,0.016).
Indeed, our results showed that while the spinal cord expression of
NOS3 in sham-operated NOS1-KO mice was significantly higher
than those presented in WT and NOS2-KO mice (one way
ANOVA, p,0.005), non significant differences between genotypes
were found at 21 days after nerve injury.
The protein levels of NOS3 in the spinal cord from sham-
operated and sciatic nerve-injured WT, NOS2-KO and NOS1-
KO mice are shown in Fig. 4B. The two way ANOVA showed a
significant effect of the genotype (p,0.015) and surgery (p,0.034)
and according to what occurs with the mRNA expression, while
the NOS3 expression in sham-operated NOS1-KO mice was
significantly higher to than those observed in sham-operated WT
or NOS2-KO mice (one way ANOVA, p,0.006), these
differences between genotypes disappear after sciatic nerve
ligation.
Discussion
The present study demonstrates for first time the participation
of NOS1 and NOS2 in the development and maintenance of
thermal hyperalgesia and thermal allodynia induced by the
chronic constriction of sciatic nerve and suggests that the increased
spinal cord expression of NOS1 is regulated by NOS2, and might
be responsible for the maintenance of chronic peripheral
neuropathic pain in mice. Our data also indicate that the
Figure 3. Spinal cord expression of NOS2 in WT and NOS1-KO
mice. The relative NOS2 mRNA (A) and protein (B) expression in the
ipsilateral site of the lumbar section of the spinal cord from sham-
operated (SH) and sciatic nerve-injured (SNI) WT and NOS1-KO mice at
21 days after sciatic nerve ligation are represented. In both figures,
* indicates significant differences when compared sciatic nerve-injured
NOS1-KO mice vs. sham-operated NOS1-KO animals (* p,0.05, one-way
ANOVA followed by Student-Newman-Keuls test). A representative
example of Western blots for NOS2 protein (130 kDa) in which b-actin
(43 kDa) was used as a loading control is shown in C. Data are
expressed as mean values 6 SEM; n=4–5 samples per group.
doi:10.1371/journal.pone.0014321.g003
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might compensates for the lack of NOS1 under basal conditions
but not after sciatic nerve ligation.
Our results showed that the mechanical allodynia and thermal
hyperalgesia induced by sciatic nerve injury was completely
abolished in both NOS knockout mice, while thermal allodynia
was significantly attenuated and completely abolished in NOS1-
KO and NOS2-KO animals, respectively. In accordance to our
results, the pharmacological inhibition of NOS1 or NOS2
isoenzymes as well as the genetic deletion of NOS1 both attenuate
the mechanical hypersensitivity observed after the spinal or sciatic
nerve injury in mice [4–5,15]. Despite that, our study extended
these findings and provides the first evidence that the targeted
disruption of NOS1 or NOS2 genes also abolishes or diminishes
the thermal hyperalgesia and thermal allodynia, the other major
behavioral manifestations of neuropathic pain observed in WT
mice from days 1 to 21 following sciatic nerve ligation. Before
surgery, similar baseline withdrawal thresholds to mechanical and
thermal stimuli were found in WT and both knockout mice.
Responses of sham-operated mice also remained unchanged in
NOS1 or NOS2 knockout mice as compared to WT. These results
indicate that in the absence of nerve injury, the nitric oxide
synthesized by NOS1 or NOS2 do not seems to tonically modulate
the mechanical and thermal nociceptive sensitivity [13,16].
Summing up, our data demonstrated that nitric oxide synthesized
by both NOS1 and NOS2 isoenzymes is involved in the
development and maintenance of sciatic nerve injury-induced
neuropathic pain.
It is well known that nitric oxide generated by NOS1 or NOS2
also contributes to the processing of nociceptive signals induced by
other types of chronic pain such as inflammatory [17]. In
accordance, our and other previous studies have revealed the
different roles played by nitric oxide synthesized by NOS1 or
NOS2 in the maintenance of mechanical allodynia and thermal
hyperalgesia induced by inflammatory pain [16,18]. Surprisingly,
the behavioral data of this study show that both enzymes (NOS1
and NOS2) have a similar participation in the expression of sciatic
nerve injury-induced mechanical allodynia and thermal hyperal-
gesia. Thus, it is only in the maintenance of sciatic nerve injury-
induced thermal allodynia where NOS2 seems to be more
implicated than NOS1. These results support the hypothesis that
the involvement of each NOS enzyme varies according to the type
of nociceptive stimulus [3,5,19].
The molecular mechanisms implicated in the neuropathic pain
states are not clear. However, one consequence of nerve injuries is
the manifestation of adaptive changes in the expression of diverse
receptors, channels and enzymes, such as NOS in the dorsal root
ganglia and the spinal cord of nerve injured animals. At present,
the possible effects of chronic sciatic nerve ligation on the
induction of NOS enzymes in the spinal cord are not completely
elucidated. Our data showed that peripheral neuropathic pain
increases the transcription and expression of NOS1 in the spinal
cord of WT mice, indicating that NOS1 might be the main
responsible for the maintenance of peripheral neuropathic pain
after the total sciatic nerve ligation. In accordance to our results,
an increase in the spinal cord expression of NOS1 at 14 days after
nerve injury have been also demonstrated although the expression
of this isoenzyme on day 7
th after injury remains unaltered [5,7–
8]. These findings indicate that the NOS1 spinal cord changes
induced by nerve injury could be related to the time point after
surgery, suggesting that NOS1 seems to be more involved in the
late (14 and 21 days) than in the early stages of sciatic nerve lesion.
The possible alterations in NOS2 and NOS3 expression
induced by neuropathic pain have been also evaluated in this
study. Our results did not show significant changes in the
expression of NOS2 and NOS3, mRNA and protein, on day
21
th after sciatic nerve injury. In accordance to our findings,
DeAlba et al. [4] also demonstrated that the spinal cord protein
levels of NOS2 did not change at 26 days after total sciatic nerve
ligation, although an increase in the protein levels of NOS2 has
been also demonstrated in the spinal cord of WT mice at 7 or 14
days after nerve injury [8]. These data suggest that spinal NOS2
seems to be more involved in the early (7 and 14 days) than in the
late (21 and 26 days) stages of nerve injury-induced neuropathic
pain
In contrast to NOS1 and NOS2, the non significant changes in
the spinal cord expression of NOS3 in the early (7 and 14 days) or
late (21 days) phases of nerve injury suggest that this isoenzyme did
not play an essential role in the development or maintenance of
neuropathic pain [5,11].
The possible compensatory changes in the expression of other
NOS isoforms that might occurs in the spinal cord of NOS1 and
Figure 4. Spinal cord expression of NOS3 in WT, NOS2-KO and
NOS1-KO mice. The relative NOS3 mRNA (A) and protein (B)
expression in the ipsilateral site of the lumbar section of the spinal
cord from sham-operated (SH) and sciatic nerve-injured (SNI) WT, NOS2-
KO and NOS1-KO mice at 21 days after sciatic nerve ligation are
represented. In both figures, * indicates significant differences when
compared sham-operated NOS1-KO animals vs. the other groups.
(* p,0.05, one-way ANOVA followed by Student-Newman-Keuls test). A
representative example of Western blot for NOS3 protein (140 kDa) in
which b-actin (43 kDa) was used as a loading control is shown in
C. Data are expressed as mean values 6 SEM; n=4–5 samples per
group.
doi:10.1371/journal.pone.0014321.g004
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also evaluated. Our results demonstrate that in contrast to WT
mice, the spinal cord expression of NOS1 in NOS2-KO animals
was not altered by sciatic nerve injury. Therefore, we hypothesized
that the unaltered changes in NOS1 expression observed in
NOS2-KO mice and the genetic lack of NOS2 in these KO mice
might explain the absence of mechanical and thermal allodynia as
well as thermal hyperalgesia in their behavior responses after
sciatic nerve ligation.
Our results also show, for first time, that the expression of
NOS2 is up-regulated in the spinal cord of NOS1-KO mice
during chronic sciatic nerve injury-induced neuropathic pain. This
compensatory up-regulation of NOS2 in NOS1-KO mice suggests
that the increased expression of this isoenzyme might be
responsible for the thermal allodynia observed in NOS1-KO mice
at 21 days after surgery. This hypothesis was supported by the
absence of thermal allodynia observed in NOS2-KO mice at this
time point after sciatic nerve ligation. In addition, our data also
indicate that the presence of NOS2 is required for the increased
expression of NOS1 in the spinal cord whereas an enhanced
expression of NOS1 might avoid an up-regulation of NOS2 in the
spinal cord of sciatic nerve-injured mice.
In the present study, we also demonstrated that no compensa-
tory changes in the spinal cord expression of NOS3 take place in
sciatic nerve-injured NOS1 and NOS2 knockout mice as well as in
sham-operated NOS2-KO mice [12]. In addition, no compensa-
tory changes in the spinal cord expression of NOS1 gene in sham-
operated NOS2-KO mice have been also established. However,
while the disruption of NOS1 gene did not alter the mRNA or
protein levels of NOS2 in sham-operated mice a significant
increase in the spinal cord expression of NOS3 was further
demonstrated in sham-operated NOS1-KO mice [18]. These
results indicated that the compensatory changes in the spinal cord
expression of NOS3 in NOS1-KO under basal conditions does not
fully compensate for NOS1 function in neuropathic pain, which is
mainly produced by NOS2.
In summary, our results demonstrate the participation of nitric
oxide synthesized by NOS1 or NOS2 in the development and
maintenance of mechanical and thermal allodynia as well as the
thermal hyperalgesia induced by the total constriction of sciatic
nerve and propose these enzymes as interesting therapeutic targets
for the treatment of chronic peripheral neuropathic pain. Our data
also indicate that: i) the increased spinal cord expression of NOS1
plays a critical role in the maintenance of peripheral neuropathic
pain, ii) a compensatory up-regulation of NOS2 isoform takes place
in the spinal cord of sciatic nerve-injured NOS1-KO mice, and iii)
theup-regulation ofNOS1 inthespinal cord ofsciaticnerve-injured
WT mice at 21 days after surgery is modulated by NOS2.
Materials and Methods
Animals
Male NOS1-knockout mice (C57BL/6J background) and
NOS2-knockout mice (C57BL/6J background) were purchased
from Jackson Laboratories (Bar Harbor, ME, USA) and wild type
(WT) mice with the same genetic background (C57BL/6J) were
acquired from Harlan Laboratories (Barcelona, Spain). All mice
weighing 21 to 25 g were housed under 12-h/12-h light/dark
conditions in a room with controlled temperature (22uC) and
humidity (66%). Animals had free access to food and water and
were used after a minimum of 6 days acclimatization to the
housing conditions. All experiments were conducted between 9:00
AM and 5:00 PM. Animal procedures were conducted in
accordance with the guidelines of the European Communities,
Directive 86/609/EEC regulating animal research and approved
by the local ethical committee of our Institution (Comissio ´ d’Etica
en l’Experimentacio ´ Animal i Humana de la Universitat
Auto `noma de Barcelona, #00691).
Induction of neuropathic pain
Neuropathic pain was induced by the chronic constriction of the
sciatic nerve. Briefly, sciatic nerve ligation was performed under
isoflurane anesthesia (3% induction, 2% maintenance). The biceps
femoris and the gluteus superficialis were separated by blunt
dissection, and the right sciatic nerve was exposed. The injury was
produced by tying three ligatures around the sciatic nerve as
described by Bennett [20]. The ligatures (4/0 silk) were tied loosely
around the nerve with 1 mm spacing, until they elicited a brief twitch
in the respective hindlimb, which was prevented from applying a too
strong ligation, taking care to preserve epineural circulation. Sham-
operated WT and KO mice have been used as controls.
The development of mechanical and thermal allodynia, and
thermal hyperalgesia was evaluated by using the von Frey
filaments, cold plate and plantar tests, respectively. All genotypes
were tested in each paradigm on days 0, 1, 4, 7, 10, 14 and 21 after
sciatic nerve ligation or sham induction.
Nociceptive behavioural tests
Mechanical allodynia was quantified by measuring the hind
paw withdrawal response to von Frey filament stimulation. In
brief, animals were placed in a PlexiglasH box (20 cm high, 9 cm
diameter) with a wire grid bottom through which the von Frey
filaments (North Coast Medical, Inc., San Jose, CA, USA) bending
force range from 0.008 to 3.5 g, were applied by using a modified
version of the up–down paradigm, as previously reported by
Chaplan et al. [21]. The filament of 0.4 g was used first and the
3.5 g filament was used as a cut-off. Then, the strength of the next
filament was decreased or increased according to the response.
The threshold of response was calculated from the sequence of
filament strength used during the up–down procedure by using an
Excel program (Microsoft Iberia SRL, Barcelona, Spain) that
includes curve fitting of the data. Clear paw withdrawal, shaking
or licking of the paw were considered nociceptive-like responses.
Both ipsilateral and contralateral hind paws were tested. Animals
were allowed to habituate for 1 h before testing in order to allow
an appropriate behavioral immobility.
Thermal hyperalgesia was assessed as previously reported
by Hargreaves et al. [22]. Paw withdrawal latency in response to
radiant heat was measured using the plantar test apparatus (Ugo
Basile, Italy). Briefly, mice were placed in Plexiglas boxes (20 cm
high 69 cm diameter) positioned on a glass surface. The heat
source was positioned under the plantar surface of the hind paw
and activated with a light beam intensity, chosen in preliminary
studies to give baseline latencies from 8 to 10 s in control mice. A
cut-off time of 12s was used to prevent tissue damage in absence of
response. The mean paw withdrawal latencies from the ipsilateral
and contralateral hind paws were determined from the average of
3 separate trials, taken at 5 min intervals to prevent thermal
sensitization and behavioral disturbances. Animals were habituat-
ed to the environment for 1 h before the experiment to become
quiet and to allow testing.
Thermal allodynia to cold stimulus was assessed by using the
hot/cold-plate analgesia meter (Ugo Basile, Italy), previously
described by Bennett and Xie [20]. The number of elevations of
each hind paw was recorded in the mice exposed to the cold plate
(460.5uC) for 5 minutes. For each animal, a score was calculated
as the difference of number of elevations between ipsilateral and
contralateral paw.
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Tissue isolation. Sham-operated and sciatic nerve-injured
WT, NOS1-KO and NOS2-KO mice were sacrificed at 21 days
after surgery by cervical dislocation. Tissues from the ipsilateral
site of the lumbar section of the spinal cord were removed
immediately after sacrifice, frozen in liquid nitrogen and stored at
280uC until assay. Because of the small size of the unilateral
lumbar section of the spinal cord, tissues from two animals were
pooled together to obtain enough RNA or protein levels for
performing the real time-PCR or Western blot analysis.
Total RNA extraction and reverse transcription. Tissues
were homogenized in ice-cold with a homogenizer (Ultra-Turf,
T8; Ika Werke, Staufen, Germany) and the total RNA was
extracted with TRIzol reagent (Invitrogen, Renfrewshire,
England). The amount of the purified RNA (A260/A280 ratio
was $1.9) was determined by spectrophotometry. In all
experiments, 1 mg of total RNA was reverse transcribed into
cDNA using SuperScript II RNAse H
- reverse transcriptase
(Invitrogen, Renfrewshire, UK) in a final volume of 10 ml.
Negative controls were performed in which all of the
components were included except reverse transcriptase.
TaqMan probe real-time polymerase chain reaction
(PCR). The expression of NOS1, NOS2 and NOS3 was
determined by relative real-time PCR using pre-developed mice
TaqMan gene expression assays (Applied Biosystems, CA, USA) for
these genes: Mm0435189_m1 for NOS1, Mm01309902_m1 for
NOS2 and Mm00435217_m1 for NOS3. A probe against GAPDH
(Mm99999915_g1) wasused asendogenouscontrol. PCRreactions
were set up in 96-well plates containing the corresponding cDNA,
26 universal master mix (Applied Biosystems, CA, USA), the
forward and reverse primers and the TaqMan probe. The PCR
reaction mixture also contained PCR buffer, MgCl2, dNTPs, and
the thermal stable AmpliTaq GoldH DNA polymerase. The assay
was conducted using the Applied Biosystems ABI PRISM 7000
Sequence Detection System. Water controls were included to
ensure specificity. All samples were assayed in duplicate. Relative
expression of the target genes was calculated by means of the
comparative threshold cycle (CT) method [23].
Western blot analysis. The NOS1, NOS2 and NOS3
protein levels in the lumbar section of the spinal cord were
analyzed by Western blot. Tissues were homogenized in buffer
(50 mM Tris-Base, 150 nM NaCl, 1% NP-40, 2 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, 0.5 Triton X-100, 0.1%
SDS, 1 mM Na3VO4, 25 mM NaF, 0.5% protease inhibitor
cocktail, 1% phosphatise inhibitor cocktail). All reactive were
purchased at Sigma (St. Louis, MO, USA) with the exception of
NP-40 from Calbiochem (Biosciences, La Jolla, CA, USA). The
crude homogenate was solubilised 1 hour at 4uC, sonicated for 10
seconds and centrifugated at 4uC for 15 min at 7006g. The
supernatants (100 mg of total protein) were mixed with 46laemmli
loading buffer and then loaded onto 4% stacking/5% separating
SDS-polyacrylamide gels. The proteins were electrophoretically
transferred onto PVDF membrane overnight, blocked with PBST
+2% nonfat dry milk, and subsequently incubated overnight at
4uC with a polyclonal rabbit anti-NOS1 antibody (1:150, BD
Transduction Laboratories, San Diego, CA, USA), a polyclonal
rabbit anti-NOS2 antibody (1:200, Chemicon, Millipore), a
polyclonal rabbit anti-NOS3 antibody (1:100, BD Transduction
Laboratories, San Diego, CA, USA), or a monoclonal rabbit anti-
b-actin antibody (1:10.000, Sigma, St. Louis, MO, USA). b-actin
was used as a loading control. The proteins were detected by an
horseradish peroxidase-conjugated anti-rabbit secondary antibody
(GE Healthcare, Little Chalfont, Buckinghamshire, UK) and
visualized by chemiluminescence reagents provided with the ECL
kit (Amersham Pharmacia Biotech, Piscataway, NJ, USA) and
exposure onto hyperfilm (GE, Healthcare). The intensity of blots
was quantified by densitometry.
Experimental protocol. In a first set of experiments, we
assessed the influence of NOS1 or NOS2 deletion in the
development and expression of peripheral neuropathic pain.
Then, WT, NOS1-KO and NOS2-KO mice were habituated
for 1 h to the environment of the different experimental tests
during 4 days. After the habituation period, baseline responses
were established in the following sequence: von Frey filaments,
plantar and cold plate tests. After baseline measurements
neuropathic pain was induced as previously described. All
animals were tested in each paradigm on days 1, 4, 7, 10, 14
and 21 after the chronic constriction of the sciatic nerve by using
the same sequence as for baseline responses. We used sham-
operated WT, NOS1-KO and NOS2-KO mice as controls.
In a second set of experiments, we examined the mRNA and
protein levels of NOS1, NOS2 and NOS3 in the ipsilateral site of
the lumbar section of the spinal cord from sciatic nerve-injured and
sham-operated WT, NOS1-KO and NOS2-KO mice at 21 days
after surgery by using real time PCR and Western blot, respectively.
Statistical analysis. Data are expressed as mean 6 standard
error of the mean (SEM). For each knockout mice and
experimental day, data obtained in the von Frey filament
stimulation model, plantar and cold plate tests from sciatic
nerve-injured or sham-operated mice were compared by using a
two-way ANOVA repeated measures (genotype and surgery as
between factors of variation), followed by a one-way ANOVA or
the corresponding Student’s t test when required. Changes in the
expression (mRNA and protein levels) of NOS1, NOS2 and
NOS3 in the lumbar section of the spinal cord from sciatic nerve-
injured or sham-operated WT, NOS1-KO and NOS2-KO mice
at 21 days after surgery were analyzed by using a two-way
ANOVA (genotype and surgery as between factors of variation),
followed by a one-way ANOVA when required. A value of
p,0.05 was considered significant.
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